4//SEC Filing
SAVIENT PHARMACEUTICALS INC 4
Accession 0001230295-05-000212
CIK 0000722104operating
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 12:49 PM ET
Size
7.9 KB
Accession
0001230295-05-000212
Insider Transaction Report
Form 4
HAYWARD SURRY JEREMY
Director
Transactions
- Award
Option to Purchase Common Stock , $.01 par value
2005-09-30+10,000→ 10,000 totalExercise: $3.77From: 2006-09-30Exp: 2015-09-30→ Common Stock, $.01 par value per share (10,000 underlying) - Award
Common Stock, $.01 par value per share
2005-09-30$3.77/sh+2,122$8,000→ 21,046 total
Footnotes (2)
- [F1]These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-executive Chairperson of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $8,000.00, until he is no longer a non-executive Chairperson. On September 30, 2005, the fair market value of the Common Stock, based on the closing price, was $3.77.
- [F2]These options will become fully vested and immediately exercisable on 09/30/2006.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000722104
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 12:49 PM ET
- Size
- 7.9 KB